Hypermethylation of the p14ARF gene in ulcerative colitis-associated colorectal carcinogenesis

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1148-1151

  Sato, Fumiaki ^a,b   Xu, Yan ^a,b   Yin, Jing ^a,b   Mori, Yuriko ^a,b   Zou, Tong Tong ^a,b   Wang, Suna ^a,b   Desai, Kena ^a,b   Selaru, Florin M ^a,b   Abraham, John M ^a,b   Meltzer, Stephen J ^a,b   Harpaz, Noam ^c   Leytin, Anatoly ^c   Shibata, David ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P14;

ADENOCARCINOMA; ALLELE; ARTICLE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; DYSPLASIA; EARLY DIAGNOSIS; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KRUSKAL WALLIS TEST; METHYLATION; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; ULCERATIVE COLITIS;

BASE SEQUENCE; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; DNA METHYLATION; HUMANS; INTESTINAL MUCOSA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SULFITES; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0036168978     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program
2. Ulcerative colitis and colorectal cancer. A population-based study
3. Colorectal cancer in idiopathic inflammatory bowel disease
4. A genetic model for colorectal tumorigenesis
5. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions
6. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma
7. Surfing the p53 network
8. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
9. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma
10. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
11. Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas
12. p14ARF deletion and methylation in genetic pathways to glioblastomas
13. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma
14. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
15. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status
16. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett’s-associated esophageal adenocarcinomas
17. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers
18. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
19. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer
20. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis
21. Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: Effect of folate supplementation
22. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis
23. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis
24. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
25. Mutations of p53 in morphologically non-neoplastic mucosa of long- standing ulcerative colitis
26. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas
27. Fields of aberrant CpG island hypermethylation in Barrett’s esophagus and associated adenocarcinoma
28. ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors